UMU. V. Maslikova

U. V. Maslikova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


U. V. Maslikova has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Probability of allogeneic hematopoietic stem cell transplant failure depending on the recipient's killer immunoglobulin-like receptor genotype

    by U. V. Maslikova, E. G. Khamaganova, M. Yu. Drokov, I. Yu. Urybin, E. D. Mikhaltsova, Л. А. Кузьмина, E. N. Parovichnikova

    Introduction. Natural killers are the "first line" of antitumor and antiviral protection in the early stages after аllogeneic hematopoietic stem cell transplantation. Quantitative characteristics reach normal values already in the first month after the infusion of blood stem cells to the recipient. Self-tolerance of natural killers is achieved due to many receptors on their surface, but killer immunoglobulin-like receptors play a key role. Their role is to recognize "self" cells and block signals aimed at destroying their own cells. Knowledge of the functional activity of natural killers urged to studying the impact of mismatches between the inhibitory receptor gene and the ligand on the development of allogeneic hematopoietic stem cell transplant failure.The aim of research was to study the probability of the graft failure development in allogeneic hematopoietic stem cell transplantation depending on the recipient's killer immunoglobulin-like receptor genotype.Material and methods. Genotyping of killer-cell immunoglobulin-like receptors in 66 recipients of blood stem cells by the polymerase chain reaction method was performed in the study. Using an online calculator, receptors were classified as "best", "better" and "neutral" depending on the genotype. The end point of the assessment was the development of graft failure in the presence of different genotypes of immunoglobulin-like receptors in the recipient.Results. According to the data obtained, the presence of the “best” and "better" killer-cell immunoglobulin-like receptor genotype in the recipient significantly increased the risks of developing various forms of graft failure.Conclusion. The presence of the KIR2DL3 genotype in a recipient of hematopoietic stem cells significantly (by 3 times) reduces the likelihood of primary graft failure. This result is of great prognostic significance, although at present no ways of influencing it have been developed. The presence of the “best” killer immunoglobulin-like receptors genotype in the recipient increases the likelihood of developing graft failure by more than 3 times compared to the best and neutral genotype (44.4% vs. 13.4%).

  • Open Access

    Graft failure in allogeneic hematopoietic stem cell recipients: diagnosis and treatment

    by U. V. Maslikova, N. N. Popova, M. Yu. Drokov, E. G. Khamaganova

    Graft failure is a group of complications after allogeneic hematopoietic stem cell transplantation, which occurs according to different data up to 30%. The group of complications includes primary and secondary graft failure, primary, secondary and transient poor graft function and graft rejection. Diagnostic difficulties consist in the lack of unified diagnostic criteria accepted in the transplantation community and in the dual interpretation of these complications according to the foreign literature. The purpose of this literature review was to identify the most common criteria of different types of graft failure and determine the tactics of diagnosis and treatment. In this review we analyzed data from various literature sources, gave definitions of graft failure and poor graft function. We analyzed the literature data on the methods used to treat these conditions.


  • Open Access

    Ethical issues of xenotransplantation in the aspect of religious views

    by R. A. Sharifova, A. Kh. S. Al Breizat, M. M. Kaabak, U. V. Maslikova, B. I. Yaremin

    Transplantation allows us to confidently save the lives of previously doomed patients. Unfortunately, this colossal achievement of human progress has a problematic side – the shortage of donor organs. The use of animal organs could solve it. Currently, the issues of xenotransplantation have become relevant again after the experimental xenotransplantation of the kidney of a genetically modified pig in 2021, and the xenotransplantation of the heart in 2022. This practice raises a number of ethical questions. Is it ethical to put humanity at risk by saving one person? Is it ethical to limit the civil rights of a xeno-recipient? Will xenotransplantation create another reason for discrimination? Can the creation of xenochimeras be considered an unacceptable interference in the Divine plan from a religious point of view? Is it ethical to use higher animals for xenotransplantation? Will an increase in the number of xenotransplants create a risk of the identity of the human race? Will xenotransplantation create new questions about equitable organ allocation? The sources of scholars of theologians related to the main Abrahamic religions on this topic are analyzed. Consideration of theological approaches to the new ethical problems presented by xenotransplantation does not allow us to find a unanimity of opinion. However, as this new branch of medical science makes concrete clinical progress, the attitude of society, religious leaders and ordinary believers towards it will improve. From an individual point of view, Judaism does not object to xenotransplantation to prolong and save human life, even in the case of non-kosher animals with genetic modifications. The preservation of life outweighs other values almost without exception. Xenotransplantation, even from a pig, is hailed as a life-sustaining medical intervention from a Jewish ethical perspective by most authors. In Christianity, the motivation is to try to follow the example of Jesus Christ in bringing healing to all those in need. While physiological healing is important, the ultimate goal is the overall well-being of the individual, which requires spiritual, mental, and social well-being in addition to physical health. The most correct generalization about Islamic bioethical views on xenotransplantation would be that, given the state of science, the final ethical and legal definition remains ambiguous, but in general, xenotransplantation as a means of saving human life may be acceptable.


  • Open Access

    Ad memoriam. Academician Valery Grigorievich Savchenko

    by S. Yu. Pushkin, A. S. Nikolaeva, I. Ya. Aleksandrova, U. V. Maslikova

    In memory of academician V.G. Savchenko, who made an invaluable contribution to the development of the program bone marrow transplants both in Russia and in the Samara region.

  • Open Access

    COVID-19 Vaccination Issues in Solid Organ Transplant Recipients

    by E. V. Parabina, D. Yu. Konstantinov, M. M. Kaabak, N. N. Rappoport, S. Yu. Pushkin, A. A. Selyutin, A. S. Navasardyan, U. V. Maslikova, В. Э. Александрова, B. I. Yaremin

    The aim of this workis to provide basic answers to questions related to the vaccination of solid organ transplant recipients based on the latest literature sources and clinical guidelines. Vaccination of solid organ transplants and persons in constant contact with them is a mandatory measure, the provision of which is a vital measure that effectively reduces the risk of death from COVID-19. Doubts about less effectiveness in conditions of immunosuppression or the potential risk of developing adverse reactions are significantly inferior to the risk of death and the development of severe complications. Until new data become available, the vaccination regimen must strictly comply with the instructions for medical use of the drug. Before transplantation, the patient should be examined according to the screening protocol, and also consulted by the transplant doctor who supervises him. It is possible that whole virion vaccines (CoviVac) have an advantage over others when vaccinating solid organ recipients, but clinical experience in this matter has not yet been obtained.

  • Open Access

    TECHNOLOGIES FOR DEVELOPING DECISION SUPPORT SYSTEMS FOR THE DIAGNOSIS OF BLOOD DISORDERS USING CONVOLUTIONAL NEURAL NETWORKS

    by U. V. Maslikova, А. А. Супильников

    ТЕХНОЛОГИИ РАЗРАБОТКИ ПРОГРАММЫ СОДЕЙСТВИЯ ПРИНЯТИЮ РЕШЕНИЯ В ДИАГНОСТИКЕ ЗАБОЛЕВАНИЙ СИСТЕМЫ КРОВИ С ИСПОЛЬЗОВАНИЕМ СВЁРТОЧНЫХ ИСКУССТВЕННЫХ НЕЙРОННЫХ СЕТЕЙ


  • Open Access

    New challenges to infectious safety in the implementation of medical activities related to organ and tissue donation for transplantation

    by B. I. Yaremin, P. Kh. Nazarov, K. F.O. Alekberov, D. Yu. Konstantinov, E. V. Kudinova, U. V. Maslikova, M. S. Novruzbekov

    Changes in current scientific literature and regulatory documents related to the issues of infectious safety in organ and tissue donation have been analyzed. The suggestions have been given for changing the existing practices to meet new challenges. Data on threats to the safety of organ and tissue donation associated with the COVID-19 pandemic have been presented.


  • Open Access

    ULTRASOUND EXAMINATION OF BOWEL WALL THICKNESS IN PATIENTS WITH ACUTE INTESTINAL GRAFT-VERSUS-HOST DISEASE

    by M. Yu. Drokov, D. S. Dubnyak, G. A. Yatsyk, A. A. Kireeva, O. V. Pyrikova, Л. А. Кузьмина, N. N. Popova, V. A. Vasilyeva, U. V. Maslikova, E. N. Parovichnikova

    Introduction. Haematopoietic stem cell transplantation is the treatment of choice in many patients with malignant diseases of the blood system. In such patients, acute graft-versus-host disease (GvHD) associated with intestinal damage constitutes one of the most serious complications. However, the volume of stool per day, which is currently used as the main diagnostic criterion for such conditions, does not always permit a timely diagnosis.Aim. To study the possibility of using intestine ultrasound examination for the diagnosis of acute intestinal GvHD.Materials and methods. The study included 50 patients having undergone transplantation of allogeneic haematopoietic stem cells, 40 of whom showed clinical signs of intestinal GvHD (diarrhoea> 500 ml/day). The control group included 10 patients who had undergone transplantation of allogeneic haematopoietic stem cells and exhibited no signs of gastrointestinal events. All patients underwent ultrasound measurement of intestinal wall thickness.Results. Patients were divided into three groups: those with acute GvHD, those with diarrhoea of viral or infectious origin, those with diarrhoea caused by the toxic effects of chemotherapy drugs. It is shown that the walls of all intestinal sections were signifi cantly thicker in patients with acute GvHD as compared to the control group and patients with diarrhoea caused by other reasons.Conclusion. The thickening of the caecum wall (more than 3.25 mm) as detected using the ultrasound method can be used as a diagnostic sign of intestinal GvHD.Conflict of interest: the authors declare no conflict of interest.Financial disclosure: the study had no sponsorship.

  • Open Access

    Disseminated lung tuberculosis and tuberculosis meningoencephalitis after kidney transplantation

    by B. I. Yaremin, I. L. Tsygankov, L. A. Baryshnikova, A. A. Starostina, V. E. Aleksandrova, U. V. Maslikova

    В России эпидемиологическая ситуация по туберкулезу является напряженной. Вопросы точной диагностики и лечения остаются открытыми, в особенности эти вопросы востребованы в отношении пациентов после трансплантации солидных органов из-за более высокого риска развития данной патологии вследствие лекарственной иммуносупрессии. В данной статье приводится описание клинического случая пациента, у которого на фоне имеющегося стероидрезистентного отторжения возникает клиническая картина диссеминированного туберкулеза легких. Обсуждаются вопросы лекарственной терапии, а также лекарственного взаимодействия противотуберкулезных и иммуносупрессивных лекарственных средств.

  • Open Access

    An acute episode of rhabdomyolysis associated with everolimus and cabergoline intake in a postpartum kidney recipient

    by B. I. Yaremin, E. V. Parabina, U. V. Maslikova, V. E. Aleksandrova

    Трансплантация почки является одним из наиболее перспективных способов, призванных обеспечить наступление и успешное сохранение беременности у пациенток с терминальной хронической почечной недостаточностью. Многокомпонентная лекарственная терапия у таких пациенток создает риски для развития плода, в первую очередь благодаря тератогенности ингибиторов mTOR-рецепторов и микофенолатов. Кроме того, ингибиторы пролиферативного сигнала имеют сложное взаимодействие с другими лекарственными средствами, что может приводить к развитию дополнительных осложнений. К одному из них следует отнести рабдомиолиз. Приводится описание клинического случая развития острого эпизода обратимого рабдомиолиза у пациентки на фоне приема эверолимуса.